Intuitive Surgical (ISRG) will report Q2 2026 results on July 16, 2026. Investors will focus on whether strong procedure momentum, expanding adoption of the da Vinci 5 platform, and continued Ion growth can sustain the company’s double-digit revenue trajectory.
Intuitive Surgical (ISRG) will report Q2 2026 results on July 16, 2026. Investors will focus on whether strong procedure momentum, expanding adoption of the da Vinci 5 platform, and continued Ion growth can sustain the company’s double-digit revenue trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.02
Ticker Sentiment
